COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,755 Articles (22,502 medRxiv, 8,253 bioRxiv)

Most recent first Previous |  Page 134: Articles 1331-1340  | Next

Long-term neurological and gastrointestinal sequelae of SARS-CoV-2, influenza, and other neurotropic infections with and without vaccination
Konings, B., Villatoro, L., Burns, R., Barahona, G., McKnight, M., Hui, K., Tack, J., Pasricha, P. J.
10.1101/2024.07.25.24310990 — Posted: 2024-07-26
Evaluation of SARS-CoV-2 antibody response between paired fingerprick (hemaPEN) and venepuncture collected samples in children and adults
mazarakis, N., Toh, Z. Q., Nguyen, J., Higgins, R., Rudge, J., Whittle, B., Woudberg, N. J., Devine, J., Gooley, A., Lapierre, F., Crawford, N. W., Tosif, S., Licciardi, P.
10.1101/2024.07.24.24310954 — Posted: 2024-07-25
The Impact of SARS-CoV-2 nsp14 Proofreading on Nucleoside Antiviral Activity: Insights from Genetic and Pharmacological Investigations
Peng, J.-Y., Lahser, F., Warren, C., He, X., Murray, E., Wang, D.
10.1101/2024.07.24.604948 — Posted: 2024-07-25
Return to work and care use by long-COVID patients on Bonaire, Caribbean Netherlands: Are patients their needs met?
Berry, D., Marchena, G., Tiemessen, I., Vegh, A., Jaspers, L., Geubbels, E.
10.1101/2024.07.24.24309156 — Posted: 2024-07-24
Effectiveness Over Time of a Primary Series of the Original Monovalent COVID-19 Vaccines in Adults in the United States
Layton, J. B., Lloyd, P. C., Peetluk, L. S., Jiao, Y., Djibo, D. A., Gruber, J. F., Deng, J., Bui, C., Lo, A.-C., Ogilvie, R. P., Parambi, R., Miller, M. E., Song, J., Weatherby, L. B., Cho, S., Wong, H. L., Clarke, T. C., Hervol, J. R., Illei, D., Bell, E. J., Yang, G. W., Seeger, J. D., Wernecke, M., Richey, M. M., Forshee, R. A., Anderson, S. A., Chillarige, Y., McMahill-Walraven, C. N., Amend, K. L., Anthony, M. S., Shoaibi, A.
10.1101/2024.07.24.24310878 — Posted: 2024-07-24
A genus-specific nsp12 region impacts polymerase assembly in Alpha- and Gammacoronaviruses
Hoferle, P. J., Anderson, T. K., Kirchdoerfer, R. N.
10.1101/2024.07.23.604833 — Posted: 2024-07-24
Deep mutational scanning of SARS-CoV-2 Omicron BA.2.86 and epistatic emergence of the KP.3 variant
Taylor, A. L., Starr, T. N.
10.1101/2024.07.23.604853 — Posted: 2024-07-24
The presenting HLA determines fidelity of SARS-CoV-2 spike protein epitope prediction
Schutt, C. R., Birol, D., Lu, X., Yamasaki, S.
10.1101/2024.07.24.604889 — Posted: 2024-07-24
Identification of SARS-CoV-2 Persistent Infectious Epithelial Syndrome (SPIES) as a Novel Disease Entity using Clinical, Histologic, and RNA Programmatic Data
Wallach, T., Soliman, A., Agboola, J., Sharma, S., Araujo Coelho, L., Pittman, M., Chatzinakos, C., Kolokotronis, S.-O.
10.1101/2024.07.18.24310647 — Posted: 2024-07-24
Dynamics of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity
Tan, S. T., Rodriguez-Barraquer, I., Kwan, A. T., Blumberg, S., Hutchinson, J., Leidner, D., Lewnard, J. A., Sears, D., Lo, N. C.
10.1101/2024.07.23.24310889 — Posted: 2024-07-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).